Oric Pharmaceuticals (ORIC) Operating Expenses (2019 - 2026)
Oric Pharmaceuticals' (ORIC) quarterly Operating Expenses came in at $39.6 million in Q1 2026, up 21.09% YoY from $32.7 million in Q1 2025, and up 14.67% on a QoQ basis from $34.6 million in Q4 2025.
Oric Pharmaceuticals (ORIC) Operating Expenses (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals (ORIC) has 8 years of Operating Expenses data on file, last reported at $39.6 million in Q1 2026.
- Quarterly Operating Expenses rose 21.09% year-over-year to $39.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $149.9 million (up 2.24% YoY) and the FY2025 annual result came in at $143.0 million, changed 0.08% from the prior year.
- Operating Expenses climbed to $39.6 million in Q1 2026, from $34.6 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $39.6 million in Q1 2026 to a low of $20.7 million in Q2 2022.
- A 5-year average of $31.1 million and a median of $31.4 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2024 — Operating Expenses soared 44.11% — and 2025, when it retreated 12.68%.
- Tracing ORIC's Operating Expenses over 5 years: stood at $22.1 million in 2022, then jumped by 42.09% to $31.4 million in 2023, then rose by 25.91% to $39.6 million in 2024, then declined by 12.68% to $34.6 million in 2025, then rose by 14.67% to $39.6 million in 2026.
- The last three Operating Expenses figures came in at $39.6 million (Q1 2026), $34.6 million (Q4 2025), and $36.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Oric Pharmaceuticals | 1.44 Bn | 1.44 Bn | - | 45.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.30 Mn |
| Mar 31, 2026 | 39.62 Mn |
| Dec 31, 2025 | 34.55 Mn |
| Sep 30, 2025 | 36.67 Mn |
| Jun 30, 2025 | 39.06 Mn |
| Mar 31, 2025 | 32.72 Mn |
| Dec 31, 2024 | 39.57 Mn |
| Sep 30, 2024 | 38.32 Mn |
| Jun 30, 2024 | 36.02 Mn |
| Mar 31, 2024 | 28.99 Mn |
| Dec 31, 2023 | 31.43 Mn |
| Sep 30, 2023 | 28.68 Mn |
| Jun 30, 2023 | 24.99 Mn |
| Mar 31, 2023 | 25.68 Mn |
| Dec 31, 2022 | 22.12 Mn |
| Sep 30, 2022 | 25.69 Mn |
| Jun 30, 2022 | 20.70 Mn |
| Mar 31, 2022 | 23.26 Mn |
| Dec 31, 2021 | 22.81 Mn |
| Sep 30, 2021 | 18.46 Mn |